Is Aptose Biosciences Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: APTO) stock is to Strong Buy APTO stock.
Out of 3 analysts, 1 (33.33%) are recommending APTO as a Strong Buy, 2 (66.67%) are recommending APTO as a Buy, 0 (0%) are recommending APTO as a Hold, 0 (0%) are recommending APTO as a Sell, and 0 (0%) are recommending APTO as a Strong Sell.
What is APTO's revenue growth forecast for 2026-2026?
(NASDAQ: APTO) Aptose Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 38.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.27%.
Aptose Biosciences's revenue in 2024 is $0.
In 2026, APTO is forecast to generate $190,970,067 in revenue, with the lowest revenue forecast at $190,970,067 and the highest revenue forecast at $190,970,067.
What is APTO's forecast return on assets (ROA) for 2024-2027?
(NASDAQ: APTO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.
What is APTO's Price Target?
According to 3 Wall Street analysts that have issued a 1 year APTO price target, the average APTO price target is $15.33, with the highest APTO stock price forecast at $23.00 and the lowest APTO stock price forecast at $5.00.
On average, Wall Street analysts predict that Aptose Biosciences's share price could reach $15.33 by Apr 3, 2025. The average Aptose Biosciences stock price prediction forecasts a potential upside of 1,116.9% from the current APTO share price of $1.26.
What is APTO's forecast return on equity (ROE) for 2024-2027?
(NASDAQ: APTO) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.